Encision, a medical device company owning patented Active Electrode Monitoring (AEM) technology that prevents dangerous stray electrosurgical burns in minimally invasive surgery, announced that Encision has signed a supply agreement with Auris Health, Inc. part of the Johnson & Johnson medical devices company.

The agreement will have an initial term of three years. During the term, Auris has agreed to buy certain AEM technology-enabled products exclusively from Encision. Encision will receive an upfront payment and upon achieving certain milestones, a milestone payment in addition to revenues from proprietary product sales to Auris per the terms of the agreement.

"We are happy to be teaming up with Auris to drive new levels of patient safety in robotic surgery.  Encision's Active Electrode Monitoring is a proprietary and differentiating technology that shields patients and practitioners from radiant energy injuries during standard and robotic laparoscopic surgeries. We welcome this next phase to our relationship," said Gregory J. Trudel, President and CEO of Encision.

Encision Inc. designs and markets a portfolio of high-performance surgical instrumentation that delivers advances in patient safety with AEM Technology, surgical performance, and value to hospitals across a broad range of minimally invasive surgical procedures. Based in Boulder, Colorado, the company pioneered the development and deployment of Active Electrode Monitoring, AEM technology, to eliminate dangerous stray energy burns during minimally invasive procedures.